CharlesThomasMoltaMD

PubMed

• 7 citations
  Factors associated with physicians’ prescriptions for rheumatoid arthritis drugs not filled by patients
  H. Kan, Kirill Dyagilev, Peter Schulam, Suchi Saria, Hadi Kharrazi, David P. Bodycombe, Charles T. Molta, Jeffrey R. Curtis> ;Arthritis Research & Therapy. 2018 May 2
• 30 citations
  Presentation of SLE in UK primary care using the Clinical Practice Research Datalink.
  Alison Nightingale, Julie E. Davidson, C. Molta, H. Kan, Neil McHugh> ;Lupus Science & Medicine. 2017 Feb 1
• 37 citations
  Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.
  Ronald F van Vollenhoven, Michelle Petri, Daniel J. Wallace, David A. Roth, C. Molta, Anne E. Hammer, Yongqiang Tang, A. Thompson> ;Arthritis & Rheumatology. 2016 Sep 1
• Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
  Roth, D. A.,Thompson, A.,Tang, Y.,Hammer, A. E.,Molta, C. T.,Gordon, D.,Roth, D. A.,Thompson, A.,Tang, Y.,Hammer, A. E.,Molta, C. T.,Gordon, D.> ;Lupus. 2015 Sep 20
• 25 citations
  Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus
  H. Kan, Saurabh P Nagar, Jeetvan Patel, Daniel J. Wallace, C. Molta, David J. Chang> ;Clinical Therapeutics. 2016 Mar 1
• 18 citations
  Post-marketing Experiences with Belimumab in the Treatment of SLE Patients
  Anca D. Askanase, Jinoos Yazdany, C. Molta> ;Rheumatic Diseases Clinics of North America. 2014 Aug 1
• 66 citations
  Burden of Systemic Lupus Erythematosus on Employment and Work Productivity: Data From a Large Cohort in the Southeastern United States
  Cristina Drenkard, Gaobin Bao, Greg Dennis, H. Kan, Priti Jhingran, C. Molta, S. Sam Lim> ;Arthritis Care & Research. 2014 Jun 1
• 51 citations
  The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psori...
  Robert Strohal, Luis Puig, Edgardo Chouela, Tsen-Fang Tsai, Jeffrey Melin, Bruce Freundlich, C. T. Molta, Joanne Fuiman, Ronald Pedersen, Deborah Robertson> ;The Journal of Dermatological Treatment. 2013 Jun 1
• 31 citations
  Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study
  Enno Christophers, Siegfried Segaert, Gary Milligan, C. T. Molta, R. Boggs> ;The Journal of Dermatological Treatment. 2013 Jun 1
• 11 citations
  A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus
  H. Kan, Annie Guerin, Michael Kaminsky, Andrew P. Yu, Eric Q. Wu, Alfred Denio, Jhingran Priti, Siva Narayanan, C. Molta> ;Journal of Medical Economics. 2013 May 6
• 53 citations
  Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus
  Manan Shah, Sham Chaudhari, Trent P. McLaughlin, H. Kan, Benno Bechtel, G. Dennis, C. Molta> ;Clinical Therapeutics. 2013 Apr 1
• 62 citations
  Healthcare utilization and costs of systemic lupus erythematosus in Medicaid.
  H. Kan, Xue Song, Barbara H. Johnson, Benno Bechtel, Donna O'Sullivan, C. Molta> ;Biomed Research International. 2013 Jan 1
• 165 citations
  Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
  Wolfram Sterry, Jean-Paul Ortonne, Bruce Kirkham, Olivier Brocq, Deborah Robertson, Ronald Pedersen, Joanne Estojak, C. T. Molta, Bruce Freundlich> ;BMJ. 2010 Feb 3
• 4 citations
  Wegener's granulomatosis: pitfalls in the management of pulmonary disease: A case of Wegener's granulomatosis with a hilar mass.
  Meenakshi Jolly, Charles Molta, Gary S. Hoffman> ;The Journal of Rheumatology. 2000 Oct 1
• 34 citations
  Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
  Charles Molta, Olivier Meyer, Christine Dosquet, Marcela Montes de Oca, M. C. Babron, Françoise Danon, Cécile Kaplan, Sylvie Clemenceau, Françoise Castellano, Michelin...> ;Pediatrics. 1993 Dec 1
• 2 citations
  Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study.
  Micheline Levy, Charles Molta, Olivier Meyer, Catherine Dosquet, Françoise Danon, M. C. Babron, Marcella Montes de Oca> ;Contributions to Nephrology. 1992 Jan 1
• 9 citations
  HLA DR4 and B27 Antigens in Familial and Sporadic Rheumatoid Arthritis
  M. A. Khan, Frederick Wolfe, S. M. Kleinheksel, C. Molta> ;Scandinavian Journal of Rheumatology. 1987 Jan 1
• Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA.
  Collins, C. E.,Dall'Era, M.,Kan, H.,Macahilig, C.,Molta, C.,Koscielny, V.,Chang, D. J.> ;Lupus Sci Med. 2016 Feb 03
• Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
  Prinz, J. C., Fitzgerald, O., Boggs, R. I., Foehl, J., Robertson, D., Pedersen, R., Molta, C. T., Freundlich, B.> ;J Eur Acad Dermatol Venereol. 2011 May
• Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
  Daudén, E., Griffiths, C. E., Ortonne, J. P., Kragballe, K., Molta, C. T., Robertson, D., Pedersen, R., Estojak, J., Boggs, R.> ;J Eur Acad Dermatol Venereol. 2009 Dec 01
• Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
  Luger, T. A., Barker, J., Lambert, J., Yang, S., Robertson, D., Foehl, J., Molta, C. T., Boggs, R.> ;J Eur Acad Dermatol Venereol. 2009 Aug 01
• Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: report of two kindreds with study of HLA antigens and review of the ...
  Molta, C. T., Khan, M. A., Aponte, C. J., Reynolds, T. L., Macintyre, S. S.> ;Clin Exp Rheumatol. 1989 May 01
• The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics.
  Christophers, E., Barker, J. N., Griffiths, C. E., Daudén, E., Milligan, G., Molta, C., Sato, R., Boggs, R.> ;J Eur Acad Dermatol Venereol. 2010 May 01
• Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept.
  Ortonne, J. P., Taïeb, A., Ormerod, A. D., Robertson, D., Foehl, J., Pedersen, R., Molta, C., Freundlich, B.> ;Br J Dermatol. 2009 Nov 01
• [Profile of antinuclear antibodies in 14 cases of extinct systemic lupus erythematosus for more than 3 years].
  Meyer, O., Molta, C., Bourgeois, P., Haim, T., Kahn, M. F.> ;Rev Rhum Mal Osteoartic. 1990 Oct
• Join now to see all